Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.

Saved in:
Bibliographic Details
Title: Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.
Authors: Ayla AY; Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, USA., Kalavar NR; Department of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Pimentel M; Karsh Division of Gastroenterology and MAST Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Morales W; Karsh Division of Gastroenterology and MAST Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hummers LK; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Shah AA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hughes M; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.; Department of Rheumatology, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK., McMahan ZH; Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, USA.
Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 Oct 01; Vol. 64 (10), pp. 5230-5237.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1462-0332
DOI:10.1093/rheumatology/keaf197